language=javascript type=text/javascript>
var byString = "";
var sourceString = "CTV.ca News Staff";
if ((sourceString != "") && (byString != "")) {
document.write(byString + ", ");
} else {
document.write(byString);
}
</SCRIPT> CTV.ca News Staff
Updated: Tue. Mar. 1 2005 10:37 AM ET
A team of Toronto researchers says it may have found a way to offer hope to the millions of people suffering long-lasting clinical depression who have been resistant to conventional treatment.
The researchers say they have had promising results from a study on deep brain stimulation (DBS). The researchers believe the method acts as a "brain pacemaker" to make depressed people happy again by electronically stimulating the brain.
The experiment is thought to be the first demonstration of drug-free electronic mood control.
The researchers behind the study emphasize more trials are needed but hope the method could offer a new therapy for millions suffering clinical depression who have not responded to drugs, psychotherapy, or electroconvulsive therapy.
For the study, patients with untreatable clinical depression had electrodes surgically implanted deep in their brains to stimulate the brain's the subgenual cingulate region -- one of the areas involved in mood control.
The patients then had a pulse generator implant -- the pacemaker -- sewn under the skin in their chest. The wires were hooked up to provide constant brain stimulation.
The results have been described by those involved as "like a miracle."
All six volunteers reported acute effects once the current was switched on, including noticing a sudden brightening of the room and a sense of heightened awareness.
Significant clinical response was seen in four of the six study subjects, with sustained improvement through six months.
Before the treatment, the patients were deeply depressed, lacking motivation, refusing to get out of bed for days and often feeling suicidal.
"These people weren't just having a bad day," explained Dr. Helen Mayberg, a neurologist who led the research. "They were beyond suicidal; they were too apathetic and disengaged to be bothered. They described their state as dead and deader."
Afterwards, some of the test cases started going to the gym and established new businesses. And, unlike psychiatric medications, there were no psychological side effects.
For years, Rob Matte was so depressed he couldn't get out of bed.
"I couldn't work. I couldn't physically take care of myself. I couldn't bathe. I wouldn't eat," Matte told CTV's Avis Favaro.
After medication and shock therapy failed to work, Matte tried DBS and now says his depression is gone.
"The magnitude of the benefits we have seen are so striking that most patients and their families, when they see it . . . will be interested in this surgery," said Toronto Western Hospital surgeon Dr. Andres Lozano.
Two other patients, both men, lapsed back into depression within six months. But the researchers believe that fine-tuning the treatment could eventually help most cases.
The researchers believe their technique works by modulating electrical activity in the brain mood control centre.
"Our study shows that areas of the brain that are on overdrive in patients with severe depression can be pinpointed, turned down and brought to a more normal level of activity using electrical stimulation," explained Lozano. "This in turn can lead to a lifting of depression in certain patients."
While DBS has been used to treat other brain disorders such as epilepsy and Parkinson's disease, this is the first report of DBS in the subgenual region for major depression.
The treatment is not altogether a cure, since the positive effects were reversed when stimulation was turned off, but could then be returned when resumed. But Dr. Lazamo says he's encouraged.
"So far, the longest follow-up is about a year-and-a-half and the results are sustained. So patients have improved with their depression quite significantly... It's quite a striking result in this population of patients," he told Canada AM.
"Our next goal is more patients and also to introduce this surgery to other centres in Canada and throughout the world to see whether, indeed, the results are reproducible and whether we can define who should be operated, who can benefit from this type of surgery."
The study was a collaboration of scientists from The Rotman Research Institute at Baycrest Centre for Geriatric Care, the Division of Neurosurgery at Toronto Western Hospital, and the departments of Psychiatry, all affiliated with University of Toronto.
It's published in the March 3 issue of Neuron.
With files from CTV's Avis Favaro